Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
513 trades
$10.3T in total
Open-market sales
1,157 trades
$1.3B in total
Insiders filing
546 insiders
Last 7 days
Trade type
10% Owner
bioteBTMD
Open-market buy25/05/06–25/05/0725/05/08447,714 sh2 trades$3.26avg.$1,460,598.57+10.7%
bioteBTMD
Open-market buy25/04/3025/05/021,933 sh$3.30$6,378.9+0.0%
bioteBTMD
Open-market buy25/04/2125/04/238,801 sh$3.27$28,779.27+0.2%
10% Owner
bioteBTMD
Open-market buy25/04/16–25/04/1725/04/187,874 sh2 trades$3.29avg.$25,905.46+0.2%
10% Owner
bioteBTMD
Open-market buy25/04/08–25/04/0925/04/1048,439 sh2 trades$3.21avg.$155,489.19+1.2%
10% Owner
bioteBTMD
Open-market buy25/04/03–25/04/0725/04/0774,440 sh3 trades$3.19avg.$237,281.58+1.8%
10% Owner
bioteBTMD
Open-market buyAmendment25/03/13–25/03/1725/04/03856,609 sh3 trades$3.25avg.$2,788,155.5+27.9%
bioteBTMD
Open-market buy25/03/3125/04/02106,000 sh$3.32$351,920+2.7%
Director
bioteBTMD
Open-market buy25/03/1725/03/1975,000 sh2 trades$3.95avg.$296,250No record
bioteBTMD
Open-market buy25/03/1725/03/18107,794 sh$3.87$417,162.78No record
bioteBTMD
Open-market buy25/03/1725/03/1837,595 sh$3.87$145,492.65No record
bioteBTMD
Open-market buy25/03/1725/03/1838,104 sh$3.88$147,843.52+31.0%
10% Owner
bioteBTMD
Open-market buy25/03/13–25/03/1725/03/17856,609 sh3 trades$3.25avg.$2,788,155.5+27.9%
bioteBTMD
Open-market sale24/09/0924/09/1132,874 sh$6.20$203,818.8−100.0%
bioteBTMD
Open-market sale24/07/0924/07/1011,376 sh$7.57$86,116.32−25.7%
bioteBTMD
Open-market sale23/07/0523/07/066,240 sh$6.50$40,560−4.3%
bioteBTMD
Open-market sale23/04/0423/04/0610,867 sh$5.92$64,332.64−8.2%
bioteBTMD
Open-market buy23/02/0723/02/17375,000 sh$3.25$1,218,750+14.4%
Director
bioteBTMD
Open-market buy23/01/0923/01/10200,000 sh2 trades$3.00avg.$600,000No record
bioteBTMD
Open-market sale23/01/0923/01/10865,384 sh$3.00$2,596,152−100.0%